Brief: Lyell Immunopharma Says Board Chair To Take Temporary Medical Leave Of Absence
Sept 30 (Reuters) - Lyell Immunopharma Inc LYEL.O :
* LYELL IMMUNOPHARMA - RICHARD KLAUSNER, CHAIR OF BOARD,
INFORMED
CO HE WILL TAKE TEMPORARY MEDICAL LEAVE OF ABSENCE, EXPECTED TO
RETURN IN EARLY 2022
* LYELL IMMUNOPHARMA - KLAUSNER INFORMED, WILL BE RESIGNING
FROM
POSITION AS EXECUTIVE CHAIRMAN, WILL NO LONGER BE AN EMPLOYEE,
EFFECTIVE OCT 1, 2022
* LYELL IMMUNOPHARMA - BOARD HAS ELECTED CATHY FRIEDMAN,
LEAD
INDEPENDENT DIRECTOR, TO SERVE AS INTERIM CHAIR OF BOARD DURING
KLAUSNER’S ABSENCE
Further company coverage: LYEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma